Literature DB >> 9284353

Modulation of excitatory synaptic transmission in locus coeruleus by multiple presynaptic metabotropic glutamate receptors.

G R Dubé1, K C Marshall.   

Abstract

Metabotropic glutamate receptors have been implicated in modulation of synaptic transmission in many different systems. This study reports the effects of selective activation of metabotropic glutamate receptors on synaptic transmission in intracellularly recorded locus coeruleus neurons in brain slice preparations. Perfusion of either L-2-amino-4-phosphonobutyric acid (L-AP4; 0.1-500 microM) or (+/-)-1-aminocyclopentane-trans-1,3,dicarboxylic acid (t-ACPD; 0.1-500 microM) caused a depression of excitatory postsynaptic potentials in a dose-dependent fashion to about 70% inhibition. Both agonists exerted their effects at relatively low concentrations with estimated EC50s of 2.6 microM and 11.5 microM for L-AP4 and t-ACPD, respectively. This inhibition was not observed with the potent group I metabotropic glutamate receptor agonist (RS)-3,5-dihydroxyphenylglycine (DHPG; 100 microM). Conversely, (R)-4-carboxy-3-hydroxyphenyl-glycine (4C-3H-PG), a group I antagonist/group II agonist, and 2R,4R-4-aminopyrrolidine-2,4-dicarboxylate (APDC), a novel and specific group II agonist, also caused an inhibition of excitatory postsynaptic potentials. Both t-ACPD and L-AP4 produced an increase in paired-pulse facilitation, and failed to change the locus coeruleus response to focally applied glutamate, indicating a presynaptic locus of action. The L-AP4 inhibition was antagonized by (S)-amino-2-methyl-4-phosphonobutanoic acid (MAP4: group III antagonist) but not by (RS)-alpha-methyl-4-carboxyphenylglycine [(RS)-MCPG; mixed antagonist], suggesting that this agonist acts through a type 4 metabotropic glutamate receptor. Conversely, t-ACPD was antagonized by MCPG and by ethyl glutamate (group II antagonist), but not by aminoindan dicarboxylic acid (AIDA; group I antagonist) or MAP4, suggesting that this agonist acts on a type 2 or 3 metabotropic glutamate receptor. Taken together, these results suggest that two pharmacologically distinct presynaptic metabotropic glutamate receptors function in an additive fashion to inhibit excitatory synaptic transmission in locus coeruleus neurons. These receptors may be involved in a feedback mechanism and as such may function as autoreceptors for excitatory amino acids.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9284353     DOI: 10.1016/s0306-4522(97)00004-3

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  4 in total

1.  Systemic pre-treatment with a group II mGlu agonist, LY379268, reduces hyperalgesia in vivo.

Authors:  E F Sharpe; A E Kingston; D Lodge; J A Monn; P M Headley
Journal:  Br J Pharmacol       Date:  2002-03       Impact factor: 8.739

2.  Glutamate-induced post-activation inhibition of locus coeruleus neurons is mediated by AMPA/kainate receptors and sodium-dependent potassium currents.

Authors:  Teresa Zamalloa; Christopher P Bailey; Joseba Pineda
Journal:  Br J Pharmacol       Date:  2009-02       Impact factor: 8.739

3.  Functional and morphological characterization of glutamate transporters in the rat locus coeruleus.

Authors:  M C Medrano; I Gerrikagoitia; L Martínez-Millán; A Mendiguren; J Pineda
Journal:  Br J Pharmacol       Date:  2013-08       Impact factor: 8.739

Review 4.  Metabotropic glutamate receptors as a new therapeutic target for malignant gliomas.

Authors:  Mery Stefani Leivas Pereira; Fábio Klamt; Chairini Cássia Thomé; Paulo Valdeci Worm; Diogo Losch de Oliveira
Journal:  Oncotarget       Date:  2017-03-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.